Footnotes
ID | footnote |
f1 |
the sales reported in this form 4 were effected under a rule 10b5-1 trading plan adopted on april 6, 2018. |
f2 |
the prices reported are weighted average prices. the shares sold on march 18, 2019 were sold in multiple transactions at prices ranging from $13.41 to $13.95, inclusive, and the shares sold on march 19, 2019 were sold in multiple transactions at prices ranging from $13.22 to $13.48, inclusive. the reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the securities and exchange commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
f3 |
the prices reported are weighted average prices. the shares sold on march 18, 2019 were sold in multiple transactions at prices ranging from $13.36 to $14.05, inclusive, and the shares sold on march 19, 2019 were sold in multiple transactions at prices ranging from $13.13 to $13.47, inclusive. the reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the securities and exchange commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
f4 |
the prices reported are weighted average prices. the shares sold on march 18, 2019 were sold in multiple transactions at prices ranging from $13.41 to $13.95 inclusive, and the shares sold on march 19, 2019 were sold in multiple transactions at prices ranging from $13.22 to $13.48, inclusive. the reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the securities and exchange commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
f5 |
the reporting person disclaims beneficial ownership of these shares. |